Michael Aicher
Director/Board Member at GENETIC SIGNATURES LIMITED
Net worth: 293 306 $ as of 2024-03-30
Profile
Michael A.
Aicher was the founder of National Genetics Institute, Inc. (founded in 1991) where he served as the Chief Executive Officer from 1991 to 2012.
He was also the founder of Alveo Technologies, Inc. (founded in 2015) where he held the position of President & Director from 2015 to 2020.
Currently, Mr. Aicher holds the position of Executive Director & Director-US Operations at Genetic Signatures Ltd.
since 2014.
He is also a Director at Techcyte, Inc. and the Chief Operating Officer at Biological Dynamics, Inc. since 2022.
In his former roles, Mr. Aicher served as the Chief Executive Officer & Director at Fabric Genomics, Inc. from 2014 to 2016.
He was the Chairman & Chief Executive Officer at Kinetic Diagnostics, Inc. and the Executive Chairman at Roswell Biotechnologies, Inc. He also served as an Independent Director at Ariosa Diagnostics, Inc. from 2013 to 2015 and as a Senior Vice President at Laboratory Corp.
of America Holdings from 2000 to 2012.
Mr. Aicher completed his undergraduate studies at the University of Redlands and holds an MBA from Columbus University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GENETIC SIGNATURES LTD.
0.35% | 2023-06-29 | 661,150 ( 0.35% ) | 293 306 $ | 2024-03-30 |
Michael Aicher active positions
| Companies | Position | Start |
|---|---|---|
| GENETIC SIGNATURES LIMITED | Director/Board Member | 2014-01-01 |
Techcyte, Inc.
 Techcyte, Inc. Packaged SoftwareTechnology Services Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013. | Director/Board Member | - |
Biological Dynamics, Inc.
 Biological Dynamics, Inc. Medical DistributorsDistribution Services Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA. | Chief Operating Officer | 2022-11-09 |
Former positions of Michael Aicher
| Companies | Position | End |
|---|---|---|
Alveo Technologies, Inc.
 Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Founder | 2020-09-30 |
Ariosa Diagnostics, Inc.
 Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Ariosa Diagnostics, Inc. offers diagnostics and genetic testing services. It focuses on improving overall patient care by developing and delivering genetic testing. The company was founded by John R. Stuelpnagel, Kenneth Song, Andrew J. Sparks, Michael E. Mitchell and Arnold R. Oliphant in 2008 and is headquartered in San Jose, CA. | Director/Board Member | 2014-12-31 |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Corporate Officer/Principal | - |
National Genetics Institute, Inc.
 National Genetics Institute, Inc. Chemicals: SpecialtyProcess Industries Part of Laboratory Corp. of America Holdings, National Genetics Institute, Inc. provides hepatitis C testing and other laboratory services. The private company is based in Los Angeles, CA. The company was founded by Andrew J. Conrad, Michael A. Aicher. National Genetics Institute was acquired by Laboratory Corp. of America Holdings on August 01, 2000. | Chief Executive Officer | 2011-12-31 |
Roswell Biotechnologies, Inc.
 Roswell Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Roswell Biotechnologies, Inc. is a company that is digitizing biology with molecular electronics to diagnose and treat diseases. The company has developed the world's first molecular electronics chip, the Roswell ME Chip™, which reads all molecules of life and provides direct real-time electrical detection of single-molecule events on-chip. The company's platform technology reduces the cost and complexity of DNA sequencing to address large markets in infectious disease surveillance and containment, precision medicine, molecular diagnostics, and DNA digital data storage. Roswell Biotechnologies was founded in 2014 by leaders in DNA sequencing and is headquartered in San Diego, CA. The company was founded by Mola Paul and Barry Merriman, with Mola Paul serving as the CEO since 2014. | Chairman | - |
Training of Michael Aicher
| University of Redlands | Undergraduate Degree |
| Columbus University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Health Services |
| GENETIC SIGNATURES LIMITED | Commercial Services |
| Private companies | 8 |
|---|---|
National Genetics Institute, Inc.
National Genetics Institute, Inc. Chemicals: SpecialtyProcess Industries Part of Laboratory Corp. of America Holdings, National Genetics Institute, Inc. provides hepatitis C testing and other laboratory services. The private company is based in Los Angeles, CA. The company was founded by Andrew J. Conrad, Michael A. Aicher. National Genetics Institute was acquired by Laboratory Corp. of America Holdings on August 01, 2000. | Process Industries |
Fabric Genomics, Inc.
 Fabric Genomics, Inc. Packaged SoftwareTechnology Services Fabric Genomics, Inc. operates as an analytical genome interpretation company. It develops scalable and fully integrated informatics systems specifically design to interpret human genome sequences for research and clinical applications. The company was founded by by Martin G. Reese, Edward S. Kiruluta, John Stuelpnagel, and Paul Billings and is headquartered in Oakland, CA. | Technology Services |
Ariosa Diagnostics, Inc.
Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Ariosa Diagnostics, Inc. offers diagnostics and genetic testing services. It focuses on improving overall patient care by developing and delivering genetic testing. The company was founded by John R. Stuelpnagel, Kenneth Song, Andrew J. Sparks, Michael E. Mitchell and Arnold R. Oliphant in 2008 and is headquartered in San Jose, CA. | Health Services |
Biological Dynamics, Inc.
Biological Dynamics, Inc. Medical DistributorsDistribution Services Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA. | Distribution Services |
Kinetic Diagnostics, Inc.
 Kinetic Diagnostics, Inc. Medical SpecialtiesHealth Technology Kinetic Diagnostics, Inc. provides precision medicine for athletes and fitness. The company was founded by James Valentine and Trisha Brown and is headquartered in Berkeley, CA. | Health Technology |
Alveo Technologies, Inc.
Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Health Technology |
Roswell Biotechnologies, Inc.
Roswell Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Roswell Biotechnologies, Inc. is a company that is digitizing biology with molecular electronics to diagnose and treat diseases. The company has developed the world's first molecular electronics chip, the Roswell ME Chip™, which reads all molecules of life and provides direct real-time electrical detection of single-molecule events on-chip. The company's platform technology reduces the cost and complexity of DNA sequencing to address large markets in infectious disease surveillance and containment, precision medicine, molecular diagnostics, and DNA digital data storage. Roswell Biotechnologies was founded in 2014 by leaders in DNA sequencing and is headquartered in San Diego, CA. The company was founded by Mola Paul and Barry Merriman, with Mola Paul serving as the CEO since 2014. | Commercial Services |
Techcyte, Inc.
Techcyte, Inc. Packaged SoftwareTechnology Services Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013. | Technology Services |
- Stock Market
- Insiders
- Michael Aicher
